Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001654954-18-009399

← back to feed
Filed
Aug 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Aug 14, 2018 56.51M sh
Operating Cash Flow Q1 2019 · Jun 30, 2018 −$189.19K
Operating Cash Flow Q1 2019 · Jun 30, 2017 −$154.27K
Cash And Equivalents Q1 2019 · Jun 30, 2018 $185.24K
Cash And Equivalents Q1 2019 · Mar 31, 2018 $109.43K
Cash And Equivalents Q1 2019 · Jun 30, 2017 $5K
Cash And Equivalents Q1 2019 · Mar 31, 2017 $32.28K
Stockholders Equity Q1 2019 · Jun 30, 2018 −$2.3M
Stockholders Equity Q1 2019 · Mar 31, 2018 −$1.87M
Current Liabilities Q1 2019 · Jun 30, 2018 $2.49M
Current Liabilities Q1 2019 · Mar 31, 2018 $1.98M
Total Liabilities Q1 2019 · Jun 30, 2018 $2.49M
Total Liabilities Q1 2019 · Mar 31, 2018 $1.98M
Current Assets Q1 2019 · Jun 30, 2018 $185.24K
Current Assets Q1 2019 · Mar 31, 2018 $109.43K
Total Assets Q1 2019 · Jun 30, 2018 $185.24K
Total Assets Q1 2019 · Mar 31, 2018 $109.43K
Sga Expense Q1 2019 · Jun 30, 2018 $124.65K
Sga Expense Q1 2019 · Jun 30, 2017 $190.73K
Rd Expense Q1 2019 · Jun 30, 2018 $111.22K
Rd Expense Q1 2019 · Jun 30, 2017 $97.19K
Net Income Q1 2019 · Jun 30, 2018 −$466.87K
Net Income Q1 2019 · Jun 30, 2017 −$352.4K